HDRN compared with LSTA: revenue, margins and what each company keeps, and the suppliers and customers both name

HDRNHadron Energy, Inc.

Mkt capRevenueRevenue

LSTALisata Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

HDRNHadron Energy, Inc.

LSTALisata Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

HDRNHadron Energy, Inc.

0.66▼−0.17%

Mkt cap$38.9MRevenue—

LSTALisata Therapeutics, Inc.

1.020.00%

Regular sessionNov 2 '26

Mkt cap$9.2MRevenue$100,000Q4 FY25

Compare

Regular sessionNov 2 '26

HDRNHadron Energy, Inc.

LSTALisata Therapeutics, Inc.

0.66▼−0.17%

Price

1.020.00%

$38.9M

Mkt cap

$9.2M

—

Revenue

$100,000Q4 FY25

HDRN0.66▼−0.17%vsLSTA1.020.00%Regular sessionNov 2 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

HDRN: latest quarter not drawable. LSTA: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only HDRN 0

None

Shared 0

No disclosed counterparties: HDRN.

Only LSTA 7

—Sanford Burnham Prebys Medical Discovery Instituteunlistedsupplier

—Australasian Gastrointestinal Clinical Trials Group (AGITG)unlistedsupplier

—University of Sydneyunlistedsupplier

—Catalentunlistedsupplier

3 more · LSTA chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

HDRN, solidLSTA, dashed